Mark Vishnepolsky, MD, MBA

Kidney Specialists of Southern Nevada; DaVita Clinical Research

Disclosure(s): No financial relationships to disclose

Poster(s):

• (P-1960) Safety and Pharmacokinetics of Long-acting SARS-CoV-2 Antibodies Tixagevimab/Cilgavimab (AZD7442) are Consistent after Repeat Dosing: Results from the PROVENT Substudy
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT